Immune checkpoint inhibitors and elderly people: A review.

Immune checkpoint inhibitors and elderly people: A review.

Item
http://www.wikidata.org/entity/Q38688111
Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200.Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages.Overcoming Barriers of Age to Enhance Efficacy of Cancer Immunotherapy: The Clout of the Extracellular Matrix.Checks and Balances in Autoimmune Vasculitis.Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven ApproachSpeed of Adoption of Immune Checkpoint Inhibitors of Programmed Cell Death 1 Protein and Comparison of Patient Ages in Clinical Practice vs Pivotal Clinical TrialsClinical and molecular characteristics associated with the efficacy of PD-1/PD-L1 inhibitors for solid tumors: a meta-analysisThe impact of immunosenescence on the efficacy of immune checkpoint inhibitors in melanoma patients: a meta-analysis
P2860

Immune checkpoint inhibitors and elderly people: A review.

Item
http://www.wikidata.org/entity/Q38688111
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Immune checkpoint inhibitors and elderly people: A review.
@en
type
label
Immune checkpoint inhibitors and elderly people: A review.
@en
prefLabel
Immune checkpoint inhibitors and elderly people: A review.
@en
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Immune checkpoint inhibitors and elderly people: A review.
@en
P2093
P304
P31
P356
10.1016/J.EJCA.2017.05.044
P478
P50
P577
P698